Dermal Fillers and Botulinum Toxin Industry Research Report 2023

Dermal Fillers and Botulinum Toxin Industry Research Report 2023


Dermal fillers help to diminish facial lines and restore volume and fullness in the face. Botulinum toxin (BTX) is a neurotoxic protein produced by the bacterium clostridium botulinum and related species. It prevents the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction and thus causes flaccid paralysis. Infection with the bacterium causes the disease botulism.

Highlights

The global Dermal Fillers and Botulinum Toxin market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
Market competition is intense. Allergan, Galderma, LG Life Science, Ipsen, Merz, etc. are the leaders of the industry. Allergan hold the largest market share of 58.7% in 2019.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Dermal Fillers and Botulinum Toxin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dermal Fillers and Botulinum Toxin.
The Dermal Fillers and Botulinum Toxin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Dermal Fillers and Botulinum Toxin market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dermal Fillers and Botulinum Toxin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights


In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Allergan
Galderma
LG Life Science
Merz
Medytox
Bloomage
Bohus BioTech
Sinclair Pharma
IMEIK
Suneva Medical
Teoxane
Luminera
SciVision Biotech
Haohai Bio
Ipsen
LIBP
US World Meds
Hugel
Daewoong

Product Type Insights

Global markets are presented by Dermal Fillers and Botulinum Toxin type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the Dermal Fillers and Botulinum Toxin are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Dermal Fillers and Botulinum Toxin segment by Type

Dermal Fillers
Botulinum Toxin

Application Insights

This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Dermal Fillers and Botulinum Toxin market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Dermal Fillers and Botulinum Toxin market.
Dermal Fillers and Botulinum Toxin segment by Application

Medical
Cosmetic

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Dermal Fillers and Botulinum Toxin market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dermal Fillers and Botulinum Toxin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Dermal Fillers and Botulinum Toxin and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Dermal Fillers and Botulinum Toxin industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dermal Fillers and Botulinum Toxin.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Dermal Fillers and Botulinum Toxin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Dermal Fillers and Botulinum Toxin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Dermal Fillers and Botulinum Toxin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.

Frequently Asked Questions

Which product segment grabbed the largest share in the Product Name market?
How is the competitive scenario of the Product Name market?
Which are the key factors aiding the Product Name market growth?
Which are the prominent players in the Product Name market?
Which region holds the maximum share in the Product Name market?
What will be the CAGR of the Product Name market during the forecast period?
Which application segment emerged as the leading segment in the Product Name market?
What key trends are likely to emerge in the Product Name market in the coming years?
What will be the Product Name market size by 2028?
Which company held the largest share in the Product Name market?


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Dermal Fillers and Botulinum Toxin Market Size (2018-2029) & (US$ Million)
2.2.2 Global Dermal Fillers and Botulinum Toxin Sales (2018-2029)
2.2.3 Global Dermal Fillers and Botulinum Toxin Market Average Price (2018-2029)
2.3 Dermal Fillers and Botulinum Toxin by Type
2.3.1 Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
1.2.2 Dermal Fillers
1.2.3 Botulinum Toxin
2.4 Dermal Fillers and Botulinum Toxin by Application
2.4.1 Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
2.4.2 Medical
2.4.3 Cosmetic
3 Market Competitive Landscape by Manufacturers
3.1 Global Dermal Fillers and Botulinum Toxin Market Competitive Situation by Manufacturers (2018 Versus 2022)
3.2 Global Dermal Fillers and Botulinum Toxin Sales (K Units) of Manufacturers (2018-2023)
3.3 Global Dermal Fillers and Botulinum Toxin Revenue of Manufacturers (2018-2023)
3.4 Global Dermal Fillers and Botulinum Toxin Average Price by Manufacturers (2018-2023)
3.5 Global Dermal Fillers and Botulinum Toxin Industry Ranking, 2021 VS 2022 VS 2023
3.6 Global Manufacturers of Dermal Fillers and Botulinum Toxin, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Dermal Fillers and Botulinum Toxin, Product Type & Application
3.8 Global Manufacturers of Dermal Fillers and Botulinum Toxin, Date of Enter into This Industry
3.9 Global Dermal Fillers and Botulinum Toxin Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Allergan
4.1.1 Allergan Company Information
4.1.2 Allergan Business Overview
4.1.3 Allergan Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2018-2023)
4.1.4 Allergan Dermal Fillers and Botulinum Toxin Product Portfolio
4.1.5 Allergan Recent Developments
4.2 Galderma
4.2.1 Galderma Company Information
4.2.2 Galderma Business Overview
4.2.3 Galderma Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2018-2023)
4.2.4 Galderma Dermal Fillers and Botulinum Toxin Product Portfolio
4.2.5 Galderma Recent Developments
4.3 LG Life Science
4.3.1 LG Life Science Company Information
4.3.2 LG Life Science Business Overview
4.3.3 LG Life Science Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2018-2023)
4.3.4 LG Life Science Dermal Fillers and Botulinum Toxin Product Portfolio
4.3.5 LG Life Science Recent Developments
4.4 Merz
4.4.1 Merz Company Information
4.4.2 Merz Business Overview
4.4.3 Merz Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2018-2023)
4.4.4 Merz Dermal Fillers and Botulinum Toxin Product Portfolio
4.4.5 Merz Recent Developments
4.5 Medytox
4.5.1 Medytox Company Information
4.5.2 Medytox Business Overview
4.5.3 Medytox Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Medytox Dermal Fillers and Botulinum Toxin Product Portfolio
6.5.5 Medytox Recent Developments
4.6 Bloomage
4.6.1 Bloomage Company Information
4.6.2 Bloomage Business Overview
4.6.3 Bloomage Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2018-2023)
4.6.4 Bloomage Dermal Fillers and Botulinum Toxin Product Portfolio
4.6.5 Bloomage Recent Developments
4.7 Bohus BioTech
4.7.1 Bohus BioTech Company Information
4.7.2 Bohus BioTech Business Overview
4.7.3 Bohus BioTech Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2018-2023)
4.7.4 Bohus BioTech Dermal Fillers and Botulinum Toxin Product Portfolio
4.7.5 Bohus BioTech Recent Developments
6.8 Sinclair Pharma
4.8.1 Sinclair Pharma Company Information
4.8.2 Sinclair Pharma Business Overview
4.8.3 Sinclair Pharma Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2018-2023)
4.8.4 Sinclair Pharma Dermal Fillers and Botulinum Toxin Product Portfolio
4.8.5 Sinclair Pharma Recent Developments
4.9 IMEIK
4.9.1 IMEIK Company Information
4.9.2 IMEIK Business Overview
4.9.3 IMEIK Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2018-2023)
4.9.4 IMEIK Dermal Fillers and Botulinum Toxin Product Portfolio
4.9.5 IMEIK Recent Developments
4.10 Suneva Medical
4.10.1 Suneva Medical Company Information
4.10.2 Suneva Medical Business Overview
4.10.3 Suneva Medical Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2018-2023)
4.10.4 Suneva Medical Dermal Fillers and Botulinum Toxin Product Portfolio
4.10.5 Suneva Medical Recent Developments
6.11 Teoxane
6.11.1 Teoxane Company Information
6.11.2 Teoxane Dermal Fillers and Botulinum Toxin Business Overview
6.11.3 Teoxane Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Teoxane Dermal Fillers and Botulinum Toxin Product Portfolio
6.11.5 Teoxane Recent Developments
6.12 Luminera
6.12.1 Luminera Company Information
6.12.2 Luminera Dermal Fillers and Botulinum Toxin Business Overview
6.12.3 Luminera Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Luminera Dermal Fillers and Botulinum Toxin Product Portfolio
6.12.5 Luminera Recent Developments
6.13 SciVision Biotech
6.13.1 SciVision Biotech Company Information
6.13.2 SciVision Biotech Dermal Fillers and Botulinum Toxin Business Overview
6.13.3 SciVision Biotech Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2018-2023)
6.13.4 SciVision Biotech Dermal Fillers and Botulinum Toxin Product Portfolio
6.13.5 SciVision Biotech Recent Developments
6.14 Haohai Bio
6.14.1 Haohai Bio Company Information
6.14.2 Haohai Bio Dermal Fillers and Botulinum Toxin Business Overview
6.14.3 Haohai Bio Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Haohai Bio Dermal Fillers and Botulinum Toxin Product Portfolio
6.14.5 Haohai Bio Recent Developments
6.15 Ipsen
6.15.1 Ipsen Company Information
6.15.2 Ipsen Dermal Fillers and Botulinum Toxin Business Overview
6.15.3 Ipsen Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Ipsen Dermal Fillers and Botulinum Toxin Product Portfolio
6.15.5 Ipsen Recent Developments
6.16 LIBP
6.16.1 LIBP Company Information
6.16.2 LIBP Dermal Fillers and Botulinum Toxin Business Overview
6.16.3 LIBP Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2018-2023)
6.16.4 LIBP Dermal Fillers and Botulinum Toxin Product Portfolio
6.16.5 LIBP Recent Developments
6.17 US World Meds
6.17.1 US World Meds Company Information
6.17.2 US World Meds Dermal Fillers and Botulinum Toxin Business Overview
6.17.3 US World Meds Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2018-2023)
6.17.4 US World Meds Dermal Fillers and Botulinum Toxin Product Portfolio
6.17.5 US World Meds Recent Developments
6.18 Hugel
6.18.1 Hugel Company Information
6.18.2 Hugel Dermal Fillers and Botulinum Toxin Business Overview
6.18.3 Hugel Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Hugel Dermal Fillers and Botulinum Toxin Product Portfolio
6.18.5 Hugel Recent Developments
6.19 Daewoong
6.19.1 Daewoong Company Information
6.19.2 Daewoong Dermal Fillers and Botulinum Toxin Business Overview
6.19.3 Daewoong Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Daewoong Dermal Fillers and Botulinum Toxin Product Portfolio
6.19.5 Daewoong Recent Developments
5 Global Dermal Fillers and Botulinum Toxin Market Scenario by Region
5.1 Global Dermal Fillers and Botulinum Toxin Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Dermal Fillers and Botulinum Toxin Sales by Region: 2018-2029
5.2.1 Global Dermal Fillers and Botulinum Toxin Sales by Region: 2018-2023
5.2.2 Global Dermal Fillers and Botulinum Toxin Sales by Region: 2024-2029
5.3 Global Dermal Fillers and Botulinum Toxin Revenue by Region: 2018-2029
5.3.1 Global Dermal Fillers and Botulinum Toxin Revenue by Region: 2018-2023
5.3.2 Global Dermal Fillers and Botulinum Toxin Revenue by Region: 2024-2029
5.4 North America Dermal Fillers and Botulinum Toxin Market Facts & Figures by Country
5.4.1 North America Dermal Fillers and Botulinum Toxin Market Size by Country: 2018 VS 2022 VS 2029
5.4.2 North America Dermal Fillers and Botulinum Toxin Sales by Country (2018-2029)
5.4.3 North America Dermal Fillers and Botulinum Toxin Revenue by Country (2018-2029)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Dermal Fillers and Botulinum Toxin Market Facts & Figures by Country
5.5.1 Europe Dermal Fillers and Botulinum Toxin Market Size by Country: 2018 VS 2022 VS 2029
5.5.2 Europe Dermal Fillers and Botulinum Toxin Sales by Country (2018-2029)
5.5.3 Europe Dermal Fillers and Botulinum Toxin Revenue by Country (2018-2029)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Dermal Fillers and Botulinum Toxin Market Facts & Figures by Country
5.6.1 Asia Pacific Dermal Fillers and Botulinum Toxin Market Size by Country: 2018 VS 2022 VS 2029
5.6.2 Asia Pacific Dermal Fillers and Botulinum Toxin Sales by Country (2018-2029)
5.6.3 Asia Pacific Dermal Fillers and Botulinum Toxin Revenue by Country (2018-2029)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Dermal Fillers and Botulinum Toxin Market Facts & Figures by Country
5.7.1 Latin America Dermal Fillers and Botulinum Toxin Market Size by Country: 2018 VS 2022 VS 2029
5.7.2 Latin America Dermal Fillers and Botulinum Toxin Sales by Country (2018-2029)
5.7.3 Latin America Dermal Fillers and Botulinum Toxin Revenue by Country (2018-2029)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Dermal Fillers and Botulinum Toxin Market Facts & Figures by Country
5.8.1 Middle East and Africa Dermal Fillers and Botulinum Toxin Market Size by Country: 2018 VS 2022 VS 2029
5.8.2 Middle East and Africa Dermal Fillers and Botulinum Toxin Sales by Country (2018-2029)
5.8.3 Middle East and Africa Dermal Fillers and Botulinum Toxin Revenue by Country (2018-2029)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Dermal Fillers and Botulinum Toxin Sales by Type (2018-2029)
6.1.1 Global Dermal Fillers and Botulinum Toxin Sales by Type (2018-2029) & (K Units)
6.1.2 Global Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2018-2029)
6.2 Global Dermal Fillers and Botulinum Toxin Revenue by Type (2018-2029)
6.2.1 Global Dermal Fillers and Botulinum Toxin Sales by Type (2018-2029) & (US$ Million)
6.2.2 Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Type (2018-2029)
6.3 Global Dermal Fillers and Botulinum Toxin Price by Type (2018-2029)
7 Segment by Application
7.1 Global Dermal Fillers and Botulinum Toxin Sales by Application (2018-2029)
7.1.1 Global Dermal Fillers and Botulinum Toxin Sales by Application (2018-2029) & (K Units)
7.1.2 Global Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2018-2029)
7.2 Global Dermal Fillers and Botulinum Toxin Revenue by Application (2018-2029)
6.2.1 Global Dermal Fillers and Botulinum Toxin Sales by Application (2018-2029) & (US$ Million)
6.2.2 Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Application (2018-2029)
7.3 Global Dermal Fillers and Botulinum Toxin Price by Application (2018-2029)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Dermal Fillers and Botulinum Toxin Value Chain Analysis
8.1.1 Dermal Fillers and Botulinum Toxin Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Dermal Fillers and Botulinum Toxin Production Mode & Process
8.2 Dermal Fillers and Botulinum Toxin Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Dermal Fillers and Botulinum Toxin Distributors
8.2.3 Dermal Fillers and Botulinum Toxin Customers
9 Global Dermal Fillers and Botulinum Toxin Analyzing Market Dynamics
9.1 Dermal Fillers and Botulinum Toxin Industry Trends
9.2 Dermal Fillers and Botulinum Toxin Industry Drivers
9.3 Dermal Fillers and Botulinum Toxin Industry Opportunities and Challenges
9.4 Dermal Fillers and Botulinum Toxin Industry Restraints
10 Report Conclusion
11 Disclaimer
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Dermal Fillers and Botulinum Toxin Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Dermal Fillers and Botulinum Toxin Sales (K Units) of Manufacturers (2018-2023)
Table 7. Global Dermal Fillers and Botulinum Toxin Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Dermal Fillers and Botulinum Toxin Revenue of Manufacturers (2018-2023)
Table 9. Global Dermal Fillers and Botulinum Toxin Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Dermal Fillers and Botulinum Toxin Average Price (US$/Unit) of Manufacturers (2018-2023)
Table 11. Global Dermal Fillers and Botulinum Toxin Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Dermal Fillers and Botulinum Toxin, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Dermal Fillers and Botulinum Toxin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. Allergan Company Information
Table 17. Allergan Business Overview
Table 18. Allergan Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 19. Allergan Dermal Fillers and Botulinum Toxin Product Portfolio
Table 20. Allergan Recent Developments
Table 21. Galderma Company Information
Table 22. Galderma Business Overview
Table 23. Galderma Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 24. Galderma Dermal Fillers and Botulinum Toxin Product Portfolio
Table 25. Galderma Recent Developments
Table 26. LG Life Science Company Information
Table 27. LG Life Science Business Overview
Table 28. LG Life Science Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 29. LG Life Science Dermal Fillers and Botulinum Toxin Product Portfolio
Table 30. LG Life Science Recent Developments
Table 31. Merz Company Information
Table 32. Merz Business Overview
Table 33. Merz Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 34. Merz Dermal Fillers and Botulinum Toxin Product Portfolio
Table 35. Merz Recent Developments
Table 36. Medytox Company Information
Table 37. Medytox Business Overview
Table 38. Medytox Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 39. Medytox Dermal Fillers and Botulinum Toxin Product Portfolio
Table 40. Medytox Recent Developments
Table 41. Bloomage Company Information
Table 42. Bloomage Business Overview
Table 43. Bloomage Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 44. Bloomage Dermal Fillers and Botulinum Toxin Product Portfolio
Table 45. Bloomage Recent Developments
Table 46. Bohus BioTech Company Information
Table 47. Bohus BioTech Business Overview
Table 48. Bohus BioTech Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 49. Bohus BioTech Dermal Fillers and Botulinum Toxin Product Portfolio
Table 50. Bohus BioTech Recent Developments
Table 51. Sinclair Pharma Company Information
Table 52. Sinclair Pharma Business Overview
Table 53. Sinclair Pharma Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 54. Sinclair Pharma Dermal Fillers and Botulinum Toxin Product Portfolio
Table 55. Sinclair Pharma Recent Developments
Table 56. IMEIK Company Information
Table 57. IMEIK Business Overview
Table 58. IMEIK Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 59. IMEIK Dermal Fillers and Botulinum Toxin Product Portfolio
Table 60. IMEIK Recent Developments
Table 61. Suneva Medical Company Information
Table 62. Suneva Medical Business Overview
Table 63. Suneva Medical Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 64. Suneva Medical Dermal Fillers and Botulinum Toxin Product Portfolio
Table 65. Suneva Medical Recent Developments
Table 66. Teoxane Company Information
Table 67. Teoxane Business Overview
Table 68. Teoxane Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 69. Teoxane Dermal Fillers and Botulinum Toxin Product Portfolio
Table 70. Teoxane Recent Developments
Table 71. Luminera Company Information
Table 72. Luminera Business Overview
Table 73. Luminera Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 74. Luminera Dermal Fillers and Botulinum Toxin Product Portfolio
Table 75. Luminera Recent Developments
Table 76. SciVision Biotech Company Information
Table 77. SciVision Biotech Business Overview
Table 78. SciVision Biotech Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 79. SciVision Biotech Dermal Fillers and Botulinum Toxin Product Portfolio
Table 80. SciVision Biotech Recent Developments
Table 81. Haohai Bio Company Information
Table 82. Haohai Bio Business Overview
Table 83. Haohai Bio Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 84. Haohai Bio Dermal Fillers and Botulinum Toxin Product Portfolio
Table 85. Haohai Bio Recent Developments
Table 86. Ipsen Company Information
Table 87. Ipsen Business Overview
Table 88. Ipsen Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 89. Ipsen Dermal Fillers and Botulinum Toxin Product Portfolio
Table 90. Ipsen Recent Developments
Table 91. LIBP Company Information
Table 92. LIBP Business Overview
Table 93. LIBP Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 94. LIBP Dermal Fillers and Botulinum Toxin Product Portfolio
Table 95. LIBP Recent Developments
Table 96. US World Meds Company Information
Table 97. US World Meds Business Overview
Table 98. US World Meds Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 99. US World Meds Dermal Fillers and Botulinum Toxin Product Portfolio
Table 100. US World Meds Recent Developments
Table 101. Hugel Company Information
Table 102. Hugel Business Overview
Table 103. Hugel Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 104. Hugel Dermal Fillers and Botulinum Toxin Product Portfolio
Table 105. Hugel Recent Developments
Table 106. Daewoong Company Information
Table 107. Daewoong Business Overview
Table 108. Daewoong Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 109. Daewoong Dermal Fillers and Botulinum Toxin Product Portfolio
Table 110. Daewoong Recent Developments
Table 111. Global Dermal Fillers and Botulinum Toxin Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 112. Global Dermal Fillers and Botulinum Toxin Sales by Region (2018-2023) & (K Units)
Table 113. Global Dermal Fillers and Botulinum Toxin Sales Market Share by Region (2018-2023)
Table 114. Global Dermal Fillers and Botulinum Toxin Sales by Region (2024-2029) & (K Units)
Table 115. Global Dermal Fillers and Botulinum Toxin Sales Market Share by Region (2024-2029)
Table 116. Global Dermal Fillers and Botulinum Toxin Revenue by Region (2018-2023) & (US$ Million)
Table 117. Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Region (2018-2023)
Table 118. Global Dermal Fillers and Botulinum Toxin Revenue by Region (2024-2029) & (US$ Million)
Table 119. Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Region (2024-2029)
Table 120. North America Dermal Fillers and Botulinum Toxin Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 121. North America Dermal Fillers and Botulinum Toxin Sales by Country (2018-2023) & (K Units)
Table 122. North America Dermal Fillers and Botulinum Toxin Sales by Country (2024-2029) & (K Units)
Table 123. North America Dermal Fillers and Botulinum Toxin Revenue by Country (2018-2023) & (US$ Million)
Table 124. North America Dermal Fillers and Botulinum Toxin Revenue by Country (2024-2029) & (US$ Million)
Table 125. Europe Dermal Fillers and Botulinum Toxin Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 126. Europe Dermal Fillers and Botulinum Toxin Sales by Country (2018-2023) & (K Units)
Table 127. Europe Dermal Fillers and Botulinum Toxin Sales by Country (2024-2029) & (K Units)
Table 128. Europe Dermal Fillers and Botulinum Toxin Revenue by Country (2018-2023) & (US$ Million)
Table 129. Europe Dermal Fillers and Botulinum Toxin Revenue by Country (2024-2029) & (US$ Million)
Table 130. Asia Pacific Dermal Fillers and Botulinum Toxin Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 131. Asia Pacific Dermal Fillers and Botulinum Toxin Sales by Country (2018-2023) & (K Units)
Table 132. Asia Pacific Dermal Fillers and Botulinum Toxin Sales by Country (2024-2029) & (K Units)
Table 133. Asia Pacific Dermal Fillers and Botulinum Toxin Revenue by Country (2018-2023) & (US$ Million)
Table 134. Asia Pacific Dermal Fillers and Botulinum Toxin Revenue by Country (2024-2029) & (US$ Million)
Table 135. Latin America Dermal Fillers and Botulinum Toxin Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 136. Latin America Dermal Fillers and Botulinum Toxin Sales by Country (2018-2023) & (K Units)
Table 137. Latin America Dermal Fillers and Botulinum Toxin Sales by Country (2024-2029) & (K Units)
Table 138. Latin America Dermal Fillers and Botulinum Toxin Revenue by Country (2018-2023) & (US$ Million)
Table 139. Latin America Dermal Fillers and Botulinum Toxin Revenue by Country (2024-2029) & (US$ Million)
Table 140. Middle East and Africa Dermal Fillers and Botulinum Toxin Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 141. Middle East and Africa Dermal Fillers and Botulinum Toxin Sales by Country (2018-2023) & (K Units)
Table 142. Middle East and Africa Dermal Fillers and Botulinum Toxin Sales by Country (2024-2029) & (K Units)
Table 143. Middle East and Africa Dermal Fillers and Botulinum Toxin Revenue by Country (2018-2023) & (US$ Million)
Table 144. Middle East and Africa Dermal Fillers and Botulinum Toxin Revenue by Country (2024-2029) & (US$ Million)
Table 145. Global Dermal Fillers and Botulinum Toxin Sales by Type (2018-2023) & (K Units)
Table 146. Global Dermal Fillers and Botulinum Toxin Sales by Type (2024-2029) & (K Units)
Table 147. Global Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2018-2023)
Table 148. Global Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2024-2029)
Table 149. Global Dermal Fillers and Botulinum Toxin Revenue by Type (2018-2023) & (US$ Million)
Table 150. Global Dermal Fillers and Botulinum Toxin Revenue by Type (2024-2029) & (US$ Million)
Table 151. Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Type (2018-2023)
Table 152. Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Type (2024-2029)
Table 153. Global Dermal Fillers and Botulinum Toxin Price by Type (2018-2023) & (US$/Unit)
Table 154. Global Dermal Fillers and Botulinum Toxin Price by Type (2024-2029) & (US$/Unit)
Table 155. Global Dermal Fillers and Botulinum Toxin Sales by Application (2018-2023) & (K Units)
Table 156. Global Dermal Fillers and Botulinum Toxin Sales by Application (2024-2029) & (K Units)
Table 157. Global Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2018-2023)
Table 158. Global Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2024-2029)
Table 159. Global Dermal Fillers and Botulinum Toxin Revenue by Application (2018-2023) & (US$ Million)
Table 160. Global Dermal Fillers and Botulinum Toxin Revenue by Application (2024-2029) & (US$ Million)
Table 161. Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Application (2018-2023)
Table 162. Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Application (2024-2029)
Table 163. Global Dermal Fillers and Botulinum Toxin Price by Application (2018-2023) & (US$/Unit)
Table 164. Global Dermal Fillers and Botulinum Toxin Price by Application (2024-2029) & (US$/Unit)
Table 165. Key Raw Materials
Table 166. Raw Materials Key Suppliers
Table 167. Dermal Fillers and Botulinum Toxin Distributors List
Table 168. Dermal Fillers and Botulinum Toxin Customers List
Table 169. Dermal Fillers and Botulinum Toxin Industry Trends
Table 170. Dermal Fillers and Botulinum Toxin Industry Drivers
Table 171. Dermal Fillers and Botulinum Toxin Industry Restraints
Table 172. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Dermal Fillers and Botulinum ToxinProduct Picture
Figure 5. Global Dermal Fillers and Botulinum Toxin Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Dermal Fillers and Botulinum Toxin Market Size (2018-2029) & (US$ Million)
Figure 7. Global Dermal Fillers and Botulinum Toxin Sales (2018-2029) & (K Units)
Figure 8. Global Dermal Fillers and Botulinum Toxin Average Price (US$/Unit) & (2018-2029)
Figure 9. Dermal Fillers Product Picture
Figure 10. Botulinum Toxin Product Picture
Figure 11. Medical Product Picture
Figure 12. Cosmetic Product Picture
Figure 13. Global Dermal Fillers and Botulinum Toxin Revenue Share by Manufacturers in 2022
Figure 14. Global Manufacturers of Dermal Fillers and Botulinum Toxin, Manufacturing Sites & Headquarters
Figure 15. Global Manufacturers of Dermal Fillers and Botulinum Toxin, Date of Enter into This Industry
Figure 16. Global Top 5 and 10 Dermal Fillers and Botulinum Toxin Players Market Share by Revenue in 2022
Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 18. Global Dermal Fillers and Botulinum Toxin Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 19. Global Dermal Fillers and Botulinum Toxin Sales by Region in 2022
Figure 20. Global Dermal Fillers and Botulinum Toxin Revenue by Region in 2022
Figure 21. North America Dermal Fillers and Botulinum Toxin Market Size by Country in 2022
Figure 22. North America Dermal Fillers and Botulinum Toxin Sales Market Share by Country (2018-2029)
Figure 23. North America Dermal Fillers and Botulinum Toxin Revenue Market Share by Country (2018-2029)
Figure 24. U.S. Dermal Fillers and Botulinum Toxin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Dermal Fillers and Botulinum Toxin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Dermal Fillers and Botulinum Toxin Market Size by Country in 2022
Figure 27. Europe Dermal Fillers and Botulinum Toxin Sales Market Share by Country (2018-2029)
Figure 28. Europe Dermal Fillers and Botulinum Toxin Revenue Market Share by Country (2018-2029)
Figure 29. Germany Dermal Fillers and Botulinum Toxin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. France Dermal Fillers and Botulinum Toxin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. U.K. Dermal Fillers and Botulinum Toxin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Italy Dermal Fillers and Botulinum Toxin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Russia Dermal Fillers and Botulinum Toxin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Asia Pacific Dermal Fillers and Botulinum Toxin Market Size by Country in 2022
Figure 35. Asia Pacific Dermal Fillers and Botulinum Toxin Sales Market Share by Country (2018-2029)
Figure 36. Asia Pacific Dermal Fillers and Botulinum Toxin Revenue Market Share by Country (2018-2029)
Figure 37. China Dermal Fillers and Botulinum Toxin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Japan Dermal Fillers and Botulinum Toxin Revenue Growth Rate (2018-2029) & (US$ Million)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings